...
hrow-img

Harrow Health Inc, Common Stock

HROW

NMQ

$34.22

-$0.21

(-0.61%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.23B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
524.41K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.76
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$9.13 L
$59.23 H
$34.22

About Harrow Health Inc, Common Stock

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. Further, the company has collaboration with Asembia to enhance provider and patient experience through nationwide digital services and hub support for harrow's branded eyecare products. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameHROWSectorS&P500
1-Week Return-3.61%-2.12%-3%
1-Month Return-19.37%-3.42%-0.73%
3-Month Return-23.99%-11.13%2.87%
6-Month Return71.7%-5.74%7.17%
1-Year Return241.86%3.97%25.31%
3-Year Return302.59%1.05%28.38%
5-Year Return377.93%34.37%81.89%
10-Year Return327.75%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue51.16M48.87M72.48M88.59M130.19M[{"date":"2019-12-31","value":39.3,"profit":true},{"date":"2020-12-31","value":37.54,"profit":true},{"date":"2021-12-31","value":55.67,"profit":true},{"date":"2022-12-31","value":68.05,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue16.75M14.46M18.21M25.38M39.64M[{"date":"2019-12-31","value":42.25,"profit":true},{"date":"2020-12-31","value":36.49,"profit":true},{"date":"2021-12-31","value":45.95,"profit":true},{"date":"2022-12-31","value":64.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit34.42M34.41M54.26M63.21M90.55M[{"date":"2019-12-31","value":38.01,"profit":true},{"date":"2020-12-31","value":38,"profit":true},{"date":"2021-12-31","value":59.92,"profit":true},{"date":"2022-12-31","value":69.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin67.26%70.41%74.87%71.35%69.55%[{"date":"2019-12-31","value":89.84,"profit":true},{"date":"2020-12-31","value":94.04,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.3,"profit":true},{"date":"2023-12-31","value":92.9,"profit":true}]
Operating Expenses35.18M33.66M52.40M61.29M90.12M[{"date":"2019-12-31","value":39.03,"profit":true},{"date":"2020-12-31","value":37.35,"profit":true},{"date":"2021-12-31","value":58.14,"profit":true},{"date":"2022-12-31","value":68.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(503.00K)(1.63M)(284.00K)(1.75M)431.00K[{"date":"2019-12-31","value":-116.71,"profit":false},{"date":"2020-12-31","value":-378.65,"profit":false},{"date":"2021-12-31","value":-65.89,"profit":false},{"date":"2022-12-31","value":-405.1,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(2.12M)(6.04M)(24.92M)(23.17M)(45.70M)[{"date":"2019-12-31","value":-212200000,"profit":false},{"date":"2020-12-31","value":-603600000,"profit":false},{"date":"2021-12-31","value":-2492400000,"profit":false},{"date":"2022-12-31","value":-2317400000,"profit":false},{"date":"2023-12-31","value":-4569600000,"profit":false}]
Pre-Tax Income(125.00K)(3.42M)(17.87M)(14.01M)(23.94M)[{"date":"2019-12-31","value":-12500000,"profit":false},{"date":"2020-12-31","value":-341500000,"profit":false},{"date":"2021-12-31","value":-1787400000,"profit":false},{"date":"2022-12-31","value":-1401100000,"profit":false},{"date":"2023-12-31","value":-2394100000,"profit":false}]
Income Taxes2.47M4.00K133.00K75.00K470.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":0.16,"profit":true},{"date":"2021-12-31","value":5.39,"profit":true},{"date":"2022-12-31","value":3.04,"profit":true},{"date":"2023-12-31","value":19.05,"profit":true}]
Income After Taxes(2.59M)(3.42M)(18.01M)(14.09M)(24.41M)[{"date":"2019-12-31","value":-259200000,"profit":false},{"date":"2020-12-31","value":-341900000,"profit":false},{"date":"2021-12-31","value":-1800700000,"profit":false},{"date":"2022-12-31","value":-1408600000,"profit":false},{"date":"2023-12-31","value":-2441100000,"profit":false}]
Income From Continuous Operations(125.00K)(3.42M)(18.01M)(14.09M)(24.41M)[{"date":"2019-12-31","value":-12500000,"profit":false},{"date":"2020-12-31","value":-341900000,"profit":false},{"date":"2021-12-31","value":-1800700000,"profit":false},{"date":"2022-12-31","value":-1408600000,"profit":false},{"date":"2023-12-31","value":-2441100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(2.59M)(3.42M)(18.01M)(14.09M)(24.41M)[{"date":"2019-12-31","value":-259200000,"profit":false},{"date":"2020-12-31","value":-341900000,"profit":false},{"date":"2021-12-31","value":-1800700000,"profit":false},{"date":"2022-12-31","value":-1408600000,"profit":false},{"date":"2023-12-31","value":-2441100000,"profit":false}]
EPS (Diluted)0.15(0.43)(0.66)(0.40)(0.74)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-286.67,"profit":false},{"date":"2021-12-31","value":-440,"profit":false},{"date":"2022-12-31","value":-266.67,"profit":false},{"date":"2023-12-31","value":-493.33,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HROW
Cash Ratio 0.76
Current Ratio 1.55
Quick Ratio 1.44

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HROW
ROA (LTM) -1.68%
ROE (LTM) -50.23%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HROW
Debt Ratio Lower is generally better. Negative is bad. 0.84
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.16

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HROW
Trailing PE NM
Forward PE NM
P/S (TTM) 7.25
P/B 20.94
Price/FCF 505
EV/R 7.91
EV/Ebitda 1255.60

FAQs

What is Harrow Health Inc share price today?

Harrow Health Inc (HROW) share price today is $34.22

Can Indians buy Harrow Health Inc shares?

Yes, Indians can buy shares of Harrow Health Inc (HROW) on Vested. To buy Harrow Health Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HROW stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Harrow Health Inc be purchased?

Yes, you can purchase fractional shares of Harrow Health Inc (HROW) via the Vested app. You can start investing in Harrow Health Inc (HROW) with a minimum investment of $1.

How to invest in Harrow Health Inc shares from India?

You can invest in shares of Harrow Health Inc (HROW) via Vested in three simple steps:

  • Click on Sign Up or Invest in HROW stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Harrow Health Inc shares
What is Harrow Health Inc 52-week high and low stock price?

The 52-week high price of Harrow Health Inc (HROW) is $59.23. The 52-week low price of Harrow Health Inc (HROW) is $9.13.

What is Harrow Health Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Harrow Health Inc (HROW) is

What is Harrow Health Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Harrow Health Inc (HROW) is 20.94

What is Harrow Health Inc dividend yield?

The dividend yield of Harrow Health Inc (HROW) is 0.00%

What is the Market Cap of Harrow Health Inc?

The market capitalization of Harrow Health Inc (HROW) is $1.23B

What is Harrow Health Inc’s stock symbol?

The stock symbol (or ticker) of Harrow Health Inc is HROW

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top